M&T Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-1,054
Closed -$254K 2054
2015
Q2
$254K Buy
1,054
+127
+14% +$33.8K ﹤0.01% 1601
2015
Q1
$262K Sell
927
-2,449
-73% -$530K ﹤0.01% 1554
2014
Q4
$526K Sell
3,376
-4,128
-55% -$762K ﹤0.01% 1173
2014
Q3
$1.78M Buy
+7,504
New +$1.91M 0.01% 654
2014
Q2
Sell
-5
Closed -$2K 1181
2014
Q1
$2K Buy
+5
New +$1.69K ﹤0.01% 1148

Other funds holding ICPT

M&T Bank's ICPT Position: Q3 2015 in Review

M&T Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2015, closing a stake of 1,054 shares — an estimated $254K sold.

M&T Bank first reported a position in ICPT in Q1 2014 and held it in 5 quarters. The position peaked at $1.78M in Q3 2014. 173 funds tracked by Wall St. Rank hold ICPT as of Q3 2015.

  • M&T Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 1,054 Intercept Pharmaceuticals, Inc. shares in Q3 2015, an estimated $254K.
  • M&T Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
  • M&T Bank's Intercept Pharmaceuticals, Inc. position peaked at $1.78M in Q3 2014.
  • 173 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.